Physician profile
Albert C Pai
NPI 1285084814
$2,265.28
in general payments reported to CMS, 2019-2025
8 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $346 · 2022: $393 · 2023: $204 · 2024: $1,104 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,104 · Education: $246 · Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,103.78 |
| Education | $246.02 |
| Food and Beverage | $176.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $1,103.78 | 2024 | Treo Abdominal Stent-Graft System |
| Abbott Laboratories | $768.27 | 2021-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $86.19 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $68.49 | 2025 | Imfinzi |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $64.15 | 2025 | |
| Zimmer Biomet Holdings, INC. | $62.82 | 2022-2023 | Ribfix Blu Advantage |
| Intuitive Surgical, INC. | $58.73 | 2022 | |
| Davol INC. | $52.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Pai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.